Deutsche Bank AG Increases GlaxoSmithKline plc (GSK) Price Target to GBX 1,720

GlaxoSmithKline plc (LON:GSK) had its price target raised by analysts at Deutsche Bank AG from GBX 1,700 ($21.51) to GBX 1,720 ($21.76) in a note issued to investors on Friday, May 12th. The brokerage currently has a “hold” rating on the stock. Deutsche Bank AG’s target price points to a potential upside of 2.08% from the company’s current price.

GSK has been the subject of a number of other reports. BNP Paribas reissued an “underperform” rating and set a GBX 1,520 ($19.23) target price on shares of GlaxoSmithKline plc in a research note on Sunday, January 15th. Jefferies Group LLC increased their target price on GlaxoSmithKline plc from GBX 1,780 ($22.52) to GBX 1,800 ($22.77) and gave the stock a “buy” rating in a research note on Friday, February 17th. Shore Capital reissued a “hold” rating on shares of GlaxoSmithKline plc in a research note on Thursday, January 12th. Beaufort Securities reissued a “buy” rating and set a GBX 1,750 ($22.14) target price on shares of GlaxoSmithKline plc in a research note on Thursday, February 16th. Finally, Goldman Sachs Group, Inc. (The) increased their target price on GlaxoSmithKline plc from GBX 1,800 ($22.77) to GBX 1,850 ($23.40) and gave the stock a “buy” rating in a research note on Tuesday, January 24th. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and nine have assigned a buy rating to the company. GlaxoSmithKline plc currently has an average rating of “Hold” and a consensus price target of GBX 1,745.17 ($22.08).

Analyst Recommendations for GlaxoSmithKline plc (LON:GSK)

GlaxoSmithKline plc (GSK) traded up 0.06% during midday trading on Friday, hitting GBX 1685.00. The company’s stock had a trading volume of 19,969,256 shares. GlaxoSmithKline plc has a one year low of GBX 1,363.00 and a one year high of GBX 1,745.56. The company’s 50-day moving average is GBX 1,647.07 and its 200 day moving average is GBX 1,604.10. The company’s market cap is GBX 82.33 billion.

The company also recently announced a dividend, which will be paid on Thursday, July 13th. Investors of record on Thursday, May 11th will be given a GBX 19 ($0.24) dividend. This represents a dividend yield of 1.21%. The ex-dividend date of this dividend is Thursday, May 11th.

COPYRIGHT VIOLATION NOTICE: This story was first posted by Transcript Daily and is owned by of Transcript Daily. If you are viewing this story on another site, it was stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this story can be read at https://transcriptdaily.com/2017/06/17/glaxosmithkline-plc-gsk-given-new-gbx-1720-price-target-at-deutsche-bank-ag-updated-updated-updated.html.

In other news, insider Emma Walmsley bought 83 shares of the business’s stock in a transaction that occurred on Tuesday, April 18th. The shares were acquired at an average cost of GBX 1,647 ($20.83) per share, with a total value of £1,367.01 ($1,729.30). Also, insider Vivienne Cox bought 335 shares of the business’s stock in a transaction that occurred on Wednesday, April 26th. The stock was purchased at an average cost of GBX 1,583 ($20.03) per share, for a total transaction of £5,303.05 ($6,708.48). Insiders purchased a total of 662 shares of company stock worth $1,067,188 over the last ninety days.

GlaxoSmithKline plc Company Profile

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.

Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply